These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Cyclosporine-associated chronic nephropathy. Myers BD; Ross J; Newton L; Luetscher J; Perlroth M N Engl J Med; 1984 Sep; 311(11):699-705. PubMed ID: 6382005 [TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic factor: a protective role after acute renal ischaemia? A room for it in kidney transplantation? Gianello P Acta Chir Belg; 1990; 90(4):143-50. PubMed ID: 2146848 [TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure]. Fontana F; Guardigli G; Cappelli M; Bernardi P G Ital Cardiol; 1988 Jul; 18(7):567-77. PubMed ID: 2976692 [TBL] [Abstract][Full Text] [Related]
13. Long-term effects of cyclosporine on hemodynamic parameters of renal allograft recipients. Abbud-Filho M; Barberato JB; Ramalho HJ; Salgueiro MC; Yamazaki WM; Paiva EV; Corrente JE; Bezas AG Transplant Proc; 1992 Oct; 24(5):1722-3. PubMed ID: 1412810 [No Abstract] [Full Text] [Related]
14. Angiotensin II as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis. Edwards BD; Chalmers RJ; O'Driscoll JB; Mitchell DM; Smith RJ; Lawson RS; Testa HJ; Ballardie FW Clin Nephrol; 1994 Jun; 41(6):350-6. PubMed ID: 8076438 [TBL] [Abstract][Full Text] [Related]
15. Modulation of abnormalities in renal haemodynamics and vasoactive mediators by nifedipine in patients with psoriasis on low-dose cyclosporin. Edwards BD; Chalmers RJ; O'Driscoll J; Lawson RS; Testa HJ; Ballardie FW Nephrol Dial Transplant; 1993; 8(10):1071-8. PubMed ID: 8272218 [TBL] [Abstract][Full Text] [Related]
16. Effect of felodipine on renal haemodynamics and tubular sodium handling in cyclosporin-treated renal transplant recipients. Sørensen SS; Skovbon H; Eiskjaer H; Thomsen K; Pedersen EB Nephrol Dial Transplant; 1992; 7(1):69-78. PubMed ID: 1316584 [TBL] [Abstract][Full Text] [Related]
17. Irreversibility of cyclosporine-induced renal function impairment in heart transplant recipients. Waser M; Maggiorini M; Binswanger U; Keusch G; Carrel T; von Segesser L; Gallino A; Turina M J Heart Lung Transplant; 1993; 12(5):846-50. PubMed ID: 8241226 [TBL] [Abstract][Full Text] [Related]
18. Effect of plasma volume expansion on hemodynamics and atrial natriuretic factor release in heart-transplant recipients. Dussaule JC; Nitenberg A; Tavolaro O; Benvenuti C; Loisance D; Castaigne A; Cachera JP; Ardaillou R Am J Cardiol; 1990 Aug; 66(4):477-83. PubMed ID: 2167005 [TBL] [Abstract][Full Text] [Related]
19. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure. Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164 [TBL] [Abstract][Full Text] [Related]
20. Comparison between glomerular filtration rate and renal plasma flow between kidney and heart transplant recipients maintained on a similar cyclosporine dosage. Lloveras JJ; Durand D; Ader JL; Tran Van T; Tack I; Rostaing L; Suc JM Transplant Proc; 1994 Feb; 26(1):248. PubMed ID: 8108961 [No Abstract] [Full Text] [Related] [Next] [New Search]